Real-World Drug Utilization of Fixed-Dose Combination Sitagliptin, Dapagliflozin, and Metformin in Type 2 Diabetes Mellitus Across Clinics in India: A Multicentric Observational Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: By Sumit Bhushan · 2026 · Read by 418 — Real-World Drug Utilization of Fixed-Dose Combination Sitagliptin, Dapagliflozin, and Metformin in Type 2 Diabetes Mellitus Across Clinics in India: A Multicentric Observational Study in Journal of Diabetes and Treatment
Institution: Glenmark Pharmaceuticals (India)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: Glenmark Pharmaceuticals
OpenAlex ID: W7130830280
